Concepedia

Kathy Hadje Georgiou

KH

Statistics

Publications

5

Citations

283

H-Index

5

Active since

2011

Affiliations

University of Cambridge(Current)

Kathy Hadje Georgiou is an author at University of Cambridge specializing in medicinal chemistry, enzyme inhibition, and drug discovery.

Publications per year

2011–2018

5

Publications

5

Specific inhibition of CK2α from an anchor outside the active site

P. Brear, Claudia De Fusco, Kathy Hadje Georgiou et al. · Chemical Science · 2016 · 73 citations · Full text

, , +13

A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066

Claudia De Fusco, P. Brear, Jessica Iegre et al. · Bioorganic & Medicinal Chemistry · 2017 · 68 citations · Full text

, , +15

Anticancer Properties of an Important Drug Lead Podophyllotoxin Can Be Efficiently Mimicked by Diverse Heterocyclic Scaffolds Accessible via One-Step Synthesis

Igor V. Magedov, Liliya V. Frolova, Madhuri Manpadi et al. · Journal of Medicinal Chemistry · 2011 · 62 citations

, , +17

A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds

Albert Isidro‐Llobet, Kathy Hadje Georgiou, Warren R. J. D. Galloway et al. · Organic & Biomolecular Chemistry · 2015 · 40 citations · Full text

, , +17

Novel non-ATP competitive small molecules targeting the CK2 α/β interface

P. Brear, Andrew J. P. North, Jessica Iegre et al. · Bioorganic & Medicinal Chemistry · 2018 · 40 citations · Full text

, , +17

1–5 of 5